Clinical Trial Update: Cardiovascular Risk in HIV Patients on Antiretroviral Therapy Therapy: The MHEART Study [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial (MHEART) assessed cardiovascular risk and endothelial function in people with HIV on antiretroviral therapy and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• HIV Infection

Snippet

Sponsor: University of Pittsburgh | Conditions: Cardiovascular Disease Risk in HIV Patients, Endothelial Function | Phase 1, Phase 2 | Status: COMPLETED